GenMark Diagnostics Current Ratio 2010-2019 | GNMK

GenMark Diagnostics current ratio from 2010 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
GenMark Diagnostics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.07B $0.02B 3.93
2018-12-31 $0.07B $0.02B 3.37
2018-09-30 $0.07B $0.02B 3.75
2018-06-30 $0.07B $0.04B 2.04
2018-03-31 $0.09B $0.03B 2.79
2017-12-31 $0.10B $0.03B 3.45
2017-09-30 $0.10B $0.04B 2.97
2017-06-30 $0.12B $0.03B 3.60
2017-03-31 $0.04B $0.02B 2.00
2016-12-31 $0.06B $0.03B 2.21
2016-09-30 $0.07B $0.02B 3.26
2016-06-30 $0.05B $0.02B 2.95
2016-03-31 $0.05B $0.01B 4.03
2015-12-31 $0.06B $0.01B 5.28
2015-09-30 $0.06B $0.01B 5.41
2015-06-30 $0.07B $0.01B 7.44
2015-03-31 $0.08B $0.01B 8.15
2014-12-31 $0.08B $0.01B 6.35
2014-09-30 $0.09B $0.01B 7.33
2014-06-30 $0.09B $0.01B 8.02
2014-03-31 $0.10B $0.01B 10.15
2013-12-31 $0.11B $0.01B 10.85
2013-09-30 $0.12B $0.01B 14.02
2013-06-30 $0.05B $0.01B 5.86
2013-03-31 $0.05B $0.01B 6.62
2012-12-31 $0.06B $0.01B 6.32
2012-09-30 $0.06B $0.01B 7.83
2012-06-30 $0.07B $0.01B 10.04
2012-03-31 $0.03B $0.01B 5.03
2011-12-31 $0.03B $0.01B 5.31
2011-09-30 $0.04B $0.01B 6.09
2011-06-30 $0.05B $0.01B 6.91
2011-03-31 $0.02B $0.00B 4.31
2010-12-31 $0.02B $0.00B 6.82
2010-09-30 $0.03B $0.00B 6.87
2010-06-30 $0.03B $0.00B 8.61
2010-03-31 $0.00B $0.00B 0.00
2009-12-31 $0.00B $0.00B 0.00
2009-09-30 $0.00B $0.00B 0.00
2009-06-30 $0.00B $0.00B 0.00
2009-03-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.392B $0.071B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $105.159B 23.00
Intuitive Surgical (ISRG) United States $55.787B 51.41
Edwards Lifesciences (EW) United States $36.025B 36.00
Fresenius Medical Care AG KGaA (FMS) Germany $23.498B 15.44
IDEXX Laboratories (IDXX) United States $21.386B 56.10
Teleflex (TFX) United States $13.465B 29.17
Hologic (HOLX) United States $12.009B 19.31
Varian Medical Systems (VAR) United States $11.869B 30.28
STERIS (STE) United Kingdom $11.399B 27.56
ABIOMED (ABMD) United States $11.388B 69.58
DexCom (DXCM) United States $10.787B 211.55
Masimo (MASI) United States $7.387B 45.26
Penumbra (PEN) United States $4.830B 204.49
Integra LifeSciences Holdings (IART) United States $4.229B 19.87
Globus Medical (GMED) United States $4.125B 25.72
Wright Medical Group (WMGI) Netherlands $3.961B 785.25
Tandem Diabetes Care (TNDM) United States $3.853B 0.00
LivaNova (LIVN) United Kingdom $3.556B 23.18
Cantel Medical (CMD) United States $2.781B 27.66
Glaukos (GKOS) United States $2.415B 0.00
Integer Holdings (ITGR) United States $2.251B 16.59
AVANOS MEDICAL, INC (AVNS) United States $2.020B 31.97
Nevro (NVRO) United States $1.833B 0.00
ShockWave Medical (SWAV) United States $1.625B 0.00
Inogen (INGN) United States $1.534B 33.96
Silk Road Medical (SILK) United States $1.427B 0.00
OPKO Health (OPK) United States $1.225B 0.00
CryoLife (CRY) United States $1.095B 108.59
Pacific Biosciences Of California (PACB) United States $1.082B 0.00
Accelerate Diagnostics (AXDX) United States $1.035B 0.00
Veracyte (VCYT) United States $1.007B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.988B 28.64
Mesa Laboratories (MLAB) United States $0.957B 39.15
Tactile Systems Technology (TCMD) United States $0.934B 137.81
Luminex (LMNX) United States $0.934B 122.12
Natus Medical (BABY) United States $0.893B 20.67
ViewRay (VRAY) United States $0.840B 0.00
Fluidigm (FLDM) United States $0.838B 0.00
Intersect ENT (XENT) United States $0.804B 0.00
AxoGen (AXGN) United States $0.799B 0.00
AngioDynamics (ANGO) United States $0.719B 25.09
Quotient (QTNT) Switzerland $0.597B 0.00
OrthoPediatrics (KIDS) United States $0.593B 0.00
Corindus Vascular Robotics (CVRS) United States $0.552B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.405B 21.71
Si-Bone (SIBN) United States $0.397B 0.00
Accuray (ARAY) United States $0.341B 0.00
RTI Surgical (RTIX) United States $0.325B 40.00
TransEnterix (TRXC) United States $0.280B 0.00
Neuronetics (STIM) United States $0.269B 0.00
SeaSpine Holdings (SPNE) United States $0.269B 0.00
Pulse Biosciences (PLSE) United States $0.258B 0.00
IRadimed (IRMD) United States $0.235B 44.89
ConforMIS (CFMS) United States $0.233B 0.00
Sientra (SIEN) United States $0.207B 0.00
CRH Medical (CRHM) Canada $0.206B 72.00
Alphatec Holdings (ATEC) United States $0.198B 0.00
Biosig Technologies (BSGM) United States $0.151B 0.00
Ekso Bionics Holdings (EKSO) United States $0.123B 0.00
T2 Biosystems (TTOO) United States $0.111B 0.00
Second Sight Medical Products (EYES) United States $0.106B 0.00
EDAP TMS (EDAP) France $0.101B 0.00
Vermillion (VRML) United States $0.094B 0.00
Soliton (SOLY) $0.094B 0.00
Sensus Healthcare (SRTS) United States $0.089B 0.00
Apollo Endosurgery (APEN) United States $0.079B 0.00
Nuvectra (NVTR) United States $0.079B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.067B 0.00
Ra Medical Systems (RMED) United States $0.062B 0.00
Helius Medical Technologies (HSDT) United States $0.058B 0.00
Titan Medical (TMDI) Canada $0.055B 0.00
Electromed (ELMD) United States $0.047B 24.26
Xtant Medical Holdings (XTNT) United States $0.040B 0.00
PAVmed (PAVM) United States $0.034B 0.00
Avinger (AVGR) United States $0.032B 0.00
Neovasc (NVCN) Canada $0.032B 0.00
Microbot Medical (MBOT) United States $0.031B 0.00
Viveve Medical (VIVE) United States $0.028B 0.00
DarioHealth (DRIO) Israel $0.028B 0.00
Lianluo Smart (LLIT) China $0.026B 0.00
Atossa Genetics (ATOS) United States $0.023B 0.00
Restoration Robotics (HAIR) United States $0.023B 0.00
Bioanalytical Systems (BASI) United States $0.020B 0.00
American Shared Hospital Services (AMS) United States $0.016B 17.94
Navidea Biopharmaceuticals (NAVB) United States $0.014B 0.00
Dynatronics (DYNT) United States $0.014B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
ReWalk Robotics (RWLK) Israel $0.012B 0.00
OBALON THERPTCS (OBLN) United States $0.009B 0.00
ENDRA Life Sciences (NDRA) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.008B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.006B 0.00
InspireMD (NSPR) Israel $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00
ALCON INC (ALC) $0.000B 0.00